C5a Receptor 抗体
(C5a Receptor (C5AR))
antibodies-online.com stands for high-quality research products. Search, find and order tools with extensive validation data, images, references. Our scientific customer service is always at your disposal if you have any questions about the selection or application of our products.
Recommended C5a Receptor 抗体
- (4)
- (6)
- (1)
Latest Publications for our C5a Receptor Products
: "Complement and neutrophil function changes after liver resection in humans." in: World journal of surgery, Vol. 33, Issue 12, pp. 2635-43, (2010) (PubMed).: "The C5a anaphylatoxin receptor CD88 is expressed in presynaptic terminals of hippocampal mossy fibres." in: Journal of neuroinflammation, Vol. 6, pp. 34, (2009) (PubMed).
: "Functional roles for C5a receptors in sepsis." in: Nature medicine, Vol. 14, Issue 5, pp. 551-7, (2008) (PubMed).
: "Complement 5a receptor inhibition improves renal allograft survival." in: Journal of the American Society of Nephrology : JASN, Vol. 19, Issue 12, pp. 2302-12, (2008) (PubMed).
: "The complement factor C5a contributes to pathology in a rat model of amyotrophic lateral sclerosis." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 181, Issue 12, pp. 8727-34, (2008) (PubMed).
: "C5L2 is critical for the biological activities of the anaphylatoxins C5a and C3a." in: Nature, Vol. 446, Issue 7132, pp. 203-7, (2007) (PubMed).
: "Complement induction in spinal cord microglia results in anaphylatoxin C5a-mediated pain hypersensitivity." in: The Journal of neuroscience : the official journal of the Society for Neuroscience, Vol. 27, Issue 32, pp. 8699-708, (2007) (PubMed).
: "C5a initiates the inflammatory cascade in immune complex peritonitis." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 173, Issue 5, pp. 3437-45, (2004) (PubMed).
: "Characterization of C5aR expression on murine myeloid and lymphoid cells by the use of a novel monoclonal antibody." in: Immunology letters, Vol. 88, Issue 1, pp. 47-52, (2003) (PubMed).
: "C5a anaphylatoxin is a major regulator of activating versus inhibitory FcgammaRs in immune complex-induced lung disease." in: The Journal of clinical investigation, Vol. 110, Issue 12, pp. 1823-30, (2002) (PubMed).